Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan

NCT01721096 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01721096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01721096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XIENCE PRIME Everolimus Eluting Coronary Stent Post Marketing Surveillance (PMS) in Japan
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
November 30, 2018
Enrollment
536 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina, coronary artery disease, coronary artery stenosis, coronary occlusion, myocardial ischemia